№4 (357) / 2018

T.Yu. Demidova
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST – A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
9-15
A.F. Verbovoy, A.V. Pashentseva, N.I. Verbovaya, O.V. Kosareva
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
16-22
M.B. Antsiferov (1), L.I. Astafyeva (2)
ACROMEGALY AND COMORBIDITY: DIAGNOSIS AND TREATMENT
23-26
N.A. Demidov (1), M.B. Antsiferov (1, 2)
MOSCOW EXPERIENCE OF APPLICATION OF A NEW LONG-ACTING INSULIN ANALOGUE
28-31
Yu.S. Lovkova, N.V. Vorokhobina, A.V. Kuznetsova
FEATURES OF MANAGEMENT OF PREGNANCY IN WOMEN WITH DIFFUSE TOXIC GOITER
32-38
A.F. Verbovoy (1), I.Yu. Kapralova (2), L.A. Sharonova (1), N.I. Verbovaya (1), I.V. Madyanov (3), R.A. Galkin (4)
RESULTS OF THE EVALUATION OF HORMONAL AND METABOLIC PARAMETERS IN WOMEN WITH HYPOTHYROIDISM DEPENDING ON COMPENSATION OF DISEASE
40-45
A.V. Kiyaev (1), O.E. Kondrashova (1), L.G. Chernykh (2), O.Yu. Pollyak (2), A.R. Yusupova (2), M.A. Slovak (3), I.O. Zaykova (1)
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
46-52
I.B. Zhurtova (1), M.Z. Ivanova (2)
PROBLEMS OF RATIONAL NUTRITION OF CHILDREN AND ADOLESCENTS AND ASSOCIATED ENDOCRINE DISORDERS
54-58
E.V. Biryukova (1), I.V. Solovyeva (1), N.M. Platonova (2)
POSSIBILITIES OF METHORMINE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: TEST OF TIME*
59-65
A.V. Pashentseva, A.F. Verbovoy, N.I. Verbovaya, E.V. Mitroshina, Yu.A. Dolgikh
MODERN POSSIBILITIES OF TREATMENT OF INSULIN RESISTANCE
66-70
T.P. Demicheva (1), M.Yu. Batuyeva (2)
DIFFICULTIES OF DIAGNOSTICS OF PRIMARY HYPERPARATHYROIDISM IN OUTPATIENT SETTINGS: CLINICAL OBSERVATION
72-74
I.P. Serebryakova, R.K. Galakhova, N.V. Vorokhobina, K.A. Balandina
RESULTS OF TREATMENT OF FEMALE PATIENT WITH CONGENITAL ADRENAL CORTICAL DYSFUNCTION, DUE TO 21-HYDROXYLASE DEFICIENCY: FROM VIRILIZATION TO FERTILITY REALIZATION
75-79

Бионика Медиа